The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer modelsClara Lemos, Bernard Haendler|Cellular Oncology|2021Cited by 42
The Potent and Selective AMPK Inhibitor BAY-3827 Shows Strong Efficacy in Androgen-Dependent Prostate Cancer ModelsClara Lemos, Bernard Haendler|Research Square|2020Cited by 1